InsidersTradesSigma
Follow the SinoMab BioScience Ltd. - B share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Market capitalisation: €1.5bn. The latest transaction was disclosed on 21 August 2026 (Other). Among the most active insiders: LIANG Fang. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
SinoMab BioScience Ltd. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades autoinmunes y cánceres. Se especializa en la investigación y comercialización de medicamentos innovadores.